<html>



<head>



<title>HHS/OIG, Audit - &quot;Review of Generic Drug Price Increases,&quot; 
(A-06-07-00042)</title>

<metaname="Keywords" content="A-06-07-00042, 
Audit Report, 
HHS Office of Inspector General (OIG), Office of Audit Services (OAS), 
October 24, 2007, 
Centers for Medicare and Medicaid Services (CMS)">

<style>
<!--
span.address
	{mso-style-parent:"";
	font-weight:bold}
-->
</style>

</head>



<body>

<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-JLFR"
height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({"gtm.start":new Date().getTime(),event:"gtm.js"});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!="dataLayer"?"&l="+l:"";j.async=true;j.src="//www.googletagmanager.com/gtm.js?id="+i+dl;f.parentNode.insertBefore(j,f);})(window,document,"script","dataLayer","GTM-JLFR");</script>
<!-- End Google Tag Manager -->




<h2><em>Department of Health and Human Services</em></h2>



<h3><b><font size="4">Office of Inspector General -- AUDIT</font></b></h3>



<font SIZE="4">
<p class="MsoBodyText"><b>&quot;</b><span style="font-family: Times New Roman; font-weight: 700">Review 
of Generic Drug Price Increases</span><b><span lang="EN" style="font-family: Times New Roman">,</span></b><span style="font-weight: 700">&quot; (A-06-07-00042)</span></p>
<p class="MsoNormal" style="margin-right:37.7pt"><b>October 24, 2007</b></p>
</font>



<hr>



<p>
<a href="60700042.pdf">
<img src="../../../images/pdf.gif" alt="PDF File" width="32" height="32" hspace="8" align="left" border="0">
Complete

Text of Report</a> is available in PDF format (276 kb). Copies can also be obtained by

contacting the Office of Public Affairs at 202-619-1343. </p>



<hr>

<strong>



<p>EXECUTIVE SUMMARY:</strong> </p>






<p class="MsoNormal">Generic drug price increases exceeded the specified 
statutory inflation factor applicable to brand-name drugs for 35 percent of the 
quarterly average manufacturer prices reviewed.&nbsp; If the provision for brand-name 
drugs were extended to generic drugs, the Medicaid program would receive 
additional rebates.&nbsp; By applying the method in the Social Security Act for 
calculating additional rebates on brand-name drugs to generic drugs<a name="tm_335544332">,</a> 
we calculated that the Medicaid program would have received a total of $966 
million in additional rebates for the top 200 generic drugs, ranked by Medicaid 
reimbursement, from 1991 through 2004. <br>
<br>
We recommended that the Centers for Medicare &amp; Medicaid Services (CMS) consider seeking legislative authority to extend the 
additional rebate provisions to generic drugs.&nbsp; CMS agreed to consider the 
recommendation when it considers future legislative proposals.</p>






</body>

</html>